SCHEDULE 13D/AAccepted Sep 30, 4:18 PM ET
Allogene Therapeutics, Inc. SCHEDULE 13D/A
Accepted (ET)
4:18 PM
Sep 30, 2026
Filed
Sep 30, 2026
Documents
1
Size
15.7 KB
Summary
Summary not available
This filing does not have a written summary yet. You can still open the original filing and its exhibits.